![]() |
Name |
Neobulgarone E
|
Molecular Formula | C32H24Cl2O8 | |
IUPAC Name* |
(10S)-4-chloro-10-[(9S)-1-chloro-2,4-dihydroxy-5-methoxy-7-methyl-10-oxo-9H-anthracen-9-yl]-1,3-dihydroxy-8-methoxy-6-methyl-10H-anthracen-9-one
|
|
SMILES |
CC1=CC2=C(C(=C1)OC)C(=O)C3=C([C@H]2[C@H]4C5=C(C(=CC(=C5)C)OC)C(=O)C6=C4C(=C(C=C6O)O)Cl)C(=C(C=C3O)O)Cl
|
|
InChI |
InChI=1S/C32H24Cl2O8/c1-11-5-13-21(19(7-11)41-3)31(39)25-15(35)9-17(37)29(33)27(25)23(13)24-14-6-12(2)8-20(42-4)22(14)32(40)26-16(36)10-18(38)30(34)28(24)26/h5-10,23-24,35-38H,1-4H3/t23-,24-/m1/s1
|
|
InChIKey |
QAZZAQNQJFRMEL-DNQXCXABSA-N
|
|
Synonyms |
Neobulgarone E; CHEMBL1643637
|
|
CAS | NA | |
PubChem CID | 10531758 | |
ChEMBL ID | CHEMBL1643637 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 607.4 | ALogp: | 7.7 |
HBD: | 4 | HBA: | 8 |
Rotatable Bonds: | 3 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 134.0 | Aromatic Rings: | 6 |
Heavy Atoms: | 42 | QED Weighted: | 0.209 |
Caco-2 Permeability: | -5.703 | MDCK Permeability: | 0.00000901 |
Pgp-inhibitor: | 0.592 | Pgp-substrate: | 0.001 |
Human Intestinal Absorption (HIA): | 0.907 | 20% Bioavailability (F20%): | 0.002 |
30% Bioavailability (F30%): | 0.998 |
Blood-Brain-Barrier Penetration (BBB): | 0 | Plasma Protein Binding (PPB): | 95.45% |
Volume Distribution (VD): | 0.171 | Fu: | 10.81% |
CYP1A2-inhibitor: | 0.712 | CYP1A2-substrate: | 0.673 |
CYP2C19-inhibitor: | 0.518 | CYP2C19-substrate: | 0.056 |
CYP2C9-inhibitor: | 0.65 | CYP2C9-substrate: | 0.897 |
CYP2D6-inhibitor: | 0.003 | CYP2D6-substrate: | 0.384 |
CYP3A4-inhibitor: | 0.012 | CYP3A4-substrate: | 0.06 |
Clearance (CL): | 4.614 | Half-life (T1/2): | 0.23 |
hERG Blockers: | 0.004 | Human Hepatotoxicity (H-HT): | 0.032 |
Drug-inuced Liver Injury (DILI): | 0.984 | AMES Toxicity: | 0.184 |
Rat Oral Acute Toxicity: | 0.074 | Maximum Recommended Daily Dose: | 0.976 |
Skin Sensitization: | 0.923 | Carcinogencity: | 0.033 |
Eye Corrosion: | 0.004 | Eye Irritation: | 0.942 |
Respiratory Toxicity: | 0.19 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002765 | ![]() |
0.878 | D09LBS | ![]() |
0.279 | ||
ENC002029 | ![]() |
0.454 | D0Z2LG | ![]() |
0.279 | ||
ENC005319 | ![]() |
0.454 | D06GCK | ![]() |
0.262 | ||
ENC006027 | ![]() |
0.423 | D07MGA | ![]() |
0.250 | ||
ENC000911 | ![]() |
0.418 | D0AZ8C | ![]() |
0.247 | ||
ENC000947 | ![]() |
0.418 | D0C1SF | ![]() |
0.243 | ||
ENC002766 | ![]() |
0.418 | D05HSC | ![]() |
0.241 | ||
ENC005390 | ![]() |
0.401 | D01XWG | ![]() |
0.240 | ||
ENC002596 | ![]() |
0.401 | D0D4HN | ![]() |
0.236 | ||
ENC005223 | ![]() |
0.376 | D0C9XJ | ![]() |
0.229 |